• Iaso Therapeutics to Showcase Novel mQβ Vaccine Platform at 2026 World Vaccine Congress

    Iaso Therapeutics will present at the 2026 World Vaccine Congress on Tuesday, March 31. President and CEO Robert Forgey, MS, MBA, will provide an overview of Iaso’s technology and commercial strategy during his live presentation at the Innovator Showcase.

    Published On: February 18, 2026

  • Iaso Therapeutics Develops Next Generation of Vaccines

    In an article in the Lansing Economic Area Partnership news, Iaso was highlighted for its work with next generation of vaccines. This is an excerpt from the article written by Genesis Lodise. A small [...]

    Published On: February 9, 2026

  • Iaso Therapeutics mentioned in Winter 2025 Edition of BioMatters

    Iaso Therapeutics was featured in the Winter 2025 Edition of BioMatters on page 22. The magazine is published by MichBio. An excerpt from the article reads: With recent acquisitions signaling strong investor interest in [...]

    Published On: February 2, 2026

  • Iaso 2026 Conference Schedule

    Iaso will be attending several industry conferences in 2026. Look for us at these upcoming first quarter conferences. BIO Partnering™ @JPM Week 2026! January 12-15, 2026 San Francisco Marriott Marquis, [...]

    Published On: November 21, 2025